Protection of foals against experimental Rhodococcus equi pneumonia by oral immunization.

The research study trialed the effects of oral vaccinations against Rhodococcus equi pneumonia in young foals. The immunization significantly reduced illness and aided in rapid lung clearance, giving evidence that this method can protect foals against severe challenges of R. equi.

Methodology of the Study

• The study comprised two groups of foals, each containing three foals aged one to three weeks old. Three more foals of similar age were kept separate as control.
• Both groups of foals were orally immunized on four separate occasions over a period of five weeks using two strains of Rhodococcus equi – one was a clinical isolate obtained from a pneumonic foal, and the other was a laboratory-passaged Congo red negative variant of that same strain.
• Three weeks after their last dose of immunization, all the foals were exposed to aerosol infection – they were subjected to about 10^10 of the pneumonic foal isolate five times over seven days.

Findings of the Study

• The control foals that were not immunized fell ill severely and had to be euthanized to spare them further suffering.
• On the other hand, the foals that were immunized with either strain were equally protected against the challenge, resulting in quick clearance of their lungs. This demonstrated that oral immunization can be effective at protecting foals against severe Rhodococcus equi challenges.
• The study also noted that the proteins associated with Congo red colony staining did not seem to play a significant role in protective immunity.

Implications of the Study

• The findings of the study suggest that oral immunization could be a feasible and effective method of protecting foals against Rhodococcus equi infections, a significant cause of pneumonia in these animals.
• The discovery that proteins associated with Congo red colony staining don’t have a significant role in the development of protective immunity against Rhodococcus equi is crucial for future research and the development of more targeted vaccines.